Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1-2 18F-FPPRGD2 PET/CT or PET/MRI Imaging of αvβ3 Integrins Expression as a Biomarker of Angiogenesis

NCT01806675 is registered in ClinicalTrials.gov with Sanjiv Sam Gambhir as lead sponsor.

NCT NCT01806675
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01806675 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1-2 18F-FPPRGD2 PET/CT or PET/MRI Imaging of αvβ3 Integrins Expression as a Biomarker of Angiogenesis
Lead sponsor
Sanjiv Sam Gambhir
Phase
Phase 1/2
Overall status
Completed
Start date
March 4, 2013
Completion date
April 30, 2019
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adult giant cell glioblastoma, adult glioblastoma, adult gliosarcoma, male breast cancer, metastatic squamous neck cancer with occult primary squamous cell carcinoma, recurrent adenoid cystic carcinoma of the oral cavity, recurrent adult brain tumor, recurrent basal cell carcinoma of the lip, recurrent colon cancer, recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity, recurrent hypopharyngeal cancer, recurrent inverted papilloma of the paranasal sinus and nasal cavity, recurrent laryngeal cancer, recurrent lip and oral cavity cancer, recurrent lymphoepithelioma of the nasopharynx, recurrent lymphoepithelioma of the oropharynx, recurrent metastatic squamous neck cancer with occult primary, recurrent midline lethal granuloma of the paranasal sinus and nasal cavity, recurrent mucoepidermoid carcinoma of the oral cavity, recurrent nasopharyngeal cancer, recurrent non-small cell lung cancer, recurrent oropharyngeal cancer, recurrent pancreatic cancer, recurrent paranasal sinus and nasal cavity cancer, recurrent rectal cancer, recurrent renal cell cancer, recurrent salivary gland cancer, stage iiia breast cancer, stage iiia non-small cell lung cancer, stage iiib breast cancer, stage iiib non-small cell lung cancer, stage iiic breast cancer, stage iv breast cancer, stage iv non-small cell lung cancer, stage iv pancreatic cancer, stage iv renal cell cancer, stage iva colon cancer, stage iva rectal cancer, stage iva salivary gland cancer, stage ivb colon cancer, stage ivb salivary gland cancer, stage ivc salivary gland cancer, tongue cancer, unspecified adult solid tumor, protocol specific